Healthcare

Healthcare Policy

Healthcare policy in the United States encompasses debates over coverage, cost, quality, and the appropriate role of government versus private markets in healthcare delivery and financing. The U.S. spends more per capita on healthcare than any other developed nation while covering a smaller share of its population, creating ongoing tension between those who favor market-based solutions and those who advocate for greater government involvement.

Updated Recently
8 min read

Policy Options Spectrum

Below are the major policy positions on this issue, arranged from one end of the spectrum to the other.

Most Government-Centered

Modeled on Medicare but expanded to cover everyone from birth. Would eliminate private insurance role in basic coverage, though some supplemental coverage might remain. Funded through taxes, projected to reduce overall healthcare spending by eliminating administrative overhead and enabling price negotiation.

Example: Canada's provincial single-payer systems; UK's National Health Service (though NHS also owns hospitals).

Expanded Government Role

Preserves private insurance while offering a government alternative. Intended to increase competition, lower premiums, and provide a fallback option. Could eventually lead to single-payer if most people choose public option ('glide path').

Example: Germany and Netherlands have regulated multi-payer systems with strong public options.

Moderate Reform

Incremental approach that addresses specific problems within existing system. Focus on closing Medicaid coverage gap, restoring enhanced subsidies, adding cost controls, and improving marketplace competition.

Example: Current ACA structure with enhanced subsidies (2021-2025 period).

Status Quo

Preserves employer-based system while maintaining government programs for specific populations. Recent changes include Medicaid work requirements, expired ACA subsidies, and Medicare drug price negotiation.

Example: Current U.S. system as of 2026 following OBBBA implementation.

Reduced Government Role

Argues that more competition and consumer choice will lower costs and improve quality. Supports repealing ACA mandates and regulations, expanding HSAs, and allowing insurance sales across state lines.

Example: Pre-ACA individual insurance market; some elements implemented in 2017-2020.

Minimal Government

Argues government intervention distorts healthcare markets and raises costs. Supports eliminating most regulations, converting government programs to defined contribution/voucher models, and relying on charity for those who cannot afford care.

Example: No developed nation operates a pure free-market healthcare system; closest examples in developing countries.

Current U.S. Status Quo

The U.S. healthcare system is a complex mix of public and private coverage. Approximately 65% of Americans have private insurance (employer-sponsored or individual), while government programs cover about 35% (Medicare for seniors/disabled, Medicaid for low-income, VA for veterans, CHIP for children). About 8% remain uninsured. The Affordable Care Act (ACA) established insurance marketplaces and Medicaid expansion, though 10 states have not expanded Medicaid. As of 2026, enhanced ACA subsidies have expired (from the IRA), causing significant premium increases for marketplace enrollees. Medicare beneficiaries are seeing lower drug costs due to negotiated prices under the Inflation Reduction Act, with 10 drugs now subject to price negotiation. The 'One Big Beautiful Bill Act' of 2025 implemented Medicaid work requirements and more frequent eligibility checks. Key Statistics: • U.S. healthcare spending: ~$4.8 trillion annually (~18% of GDP) • Per capita spending: ~$14,500 (highest in world, 2x peer nation average) • Uninsured rate: ~8% (approximately 26 million people) • Life expectancy: 78.4 years (4+ years below comparable nations) • Medicare covers ~67 million Americans (seniors and disabled) • Medicaid covers ~85 million Americans (low-income) • Employer-sponsored insurance covers ~155 million Americans • ACA marketplace enrollment: ~20 million (declining post-subsidy expiration) • Maternal mortality: 18.6 per 100,000 (3x higher than peer nations) • Administrative costs: ~15-30% of total spending (vs 2-5% in single-payer systems)

International Examples

How other nations approach this issue:

United Kingdom

National Health Service (NHS) is a government-owned and operated system. Healthcare is free at point of use, funded through general taxation. Hospitals are publicly owned; most doctors are government employees or contractors. Private insurance available for supplemental/faster care. Policies: Beveridge model; NHS founded 1948; free at point of use; gatekeeping by GPs Statistics: Spending: ~12% of GDP. Universal coverage. Life expectancy: 81 years. Wait times for elective procedures can be lengthy. Per capita spending ~$5,500 (1/3 of US). Outcomes: Universal access achieved at lower cost than US. Challenges include wait times for non-urgent care, workforce shortages, and funding pressures. High patient satisfaction despite resource constraints.

Canada

Single-payer system with provincial administration. Government pays for hospital and physician services; delivery is mostly private. Each province runs its own plan under federal standards (Canada Health Act). Private insurance for non-covered services (dental, vision, prescriptions). Policies: National Health Insurance model; provincial single-payer; private delivery; banned private insurance for covered services in most provinces Statistics: Spending: ~12% of GDP. Universal coverage. Life expectancy: 82 years. Per capita spending ~$6,300. Known for wait times for specialists and elective procedures. Outcomes: Universal coverage with no out-of-pocket for covered services. Lower administrative costs than US. Wait times remain political issue. Recent debates about allowing more private options.

Germany

Multi-payer system with mandatory health insurance. About 90% in statutory 'sickness funds' (non-profit insurers); 10% in private insurance. Employers and employees share premium costs. Strong regulation ensures comprehensive benefits and equal access. Policies: Bismarck model; 100+ competing sickness funds; mandatory coverage; income-based premiums Statistics: Spending: ~13% of GDP. Universal coverage. Life expectancy: 81 years. Per capita ~$7,800. Low wait times. High provider choice. Outcomes: Universal access with patient choice. No gatekeeping - direct specialist access. High-quality care with manageable costs. Complex administrative structure but functional.

France

Statutory health insurance covers about 80% of costs; most French have supplemental private insurance for remaining 20%. Mix of public hospitals and private practitioners. Widely considered one of world's best systems for quality and access. Policies: Social insurance model; mandatory coverage; significant cost-sharing offset by supplemental insurance; national fee schedules Statistics: Spending: ~12% of GDP. Universal coverage. Life expectancy: 82 years. Per capita ~$6,600. Minimal wait times. WHO ranked #1 in 2000. Outcomes: High-quality care with excellent access. Patient choice preserved. Cost-sharing mechanism controls some utilization. Supplemental insurance is near-universal.

Switzerland

Mandatory private insurance through competing insurers. Government subsidizes premiums for low-income residents. High cost-sharing (deductibles, copays). No employer-based insurance tradition. Often cited as model for ACA marketplace concept. Policies: Regulated private insurance; individual mandate; community-rated premiums; subsidies for low income Statistics: Spending: ~12% of GDP. Universal coverage. Life expectancy: 84 years. Per capita ~$9,600 (second-highest after US). High out-of-pocket costs. Outcomes: Universal coverage achieved through regulated private market. High quality but expensive. Significant cost-sharing. Similar to ACA concept but with stronger mandate enforcement.

Singapore

Three-tier system: Medisave (mandatory savings accounts), MediShield Life (catastrophic insurance), and Medifund (safety net for poor). Emphasizes individual responsibility and cost-consciousness. Public hospitals compete with private; prices posted publicly. Policies: Mandatory savings accounts; catastrophic insurance; means-tested safety net; price transparency; public-private competition Statistics: Spending: ~5% of GDP (among lowest in developed world). Universal coverage. Life expectancy: 84 years. Per capita ~$3,500. High quality rankings. Outcomes: Achieves good outcomes at very low cost. High individual responsibility. Government controls supply and prices. Not directly transferable to larger, more diverse nations.

Australia

Medicare (universal public insurance) covers all citizens for public hospital care and subsidizes doctor visits. About 45% also have private insurance for faster access and choice. Balanced public-private system. Policies: Universal public insurance; private insurance for choice/speed; means-tested subsidies; tax penalties for not holding private insurance Statistics: Spending: ~10% of GDP. Universal coverage. Life expectancy: 83 years. Per capita ~$6,100. Generally short wait times for urgent care. Outcomes: Universal access through public system; private option reduces public wait times. Two-tier concerns but broadly successful. Pharmaceutical Benefits Scheme controls drug costs.

Recent Major Developments

JANUARY 2026 UPDATE: • ACA Premium Increases: Enhanced premium tax credits expired December 31, 2025. KFF projects 114% average premium increase for 20+ million enrollees. Estimated 4.8 million Americans to drop coverage in 2026. • One Big Beautiful Bill Act (OBBBA) Impacts: - Ends automatic re-enrollment for premium tax credit recipients - Eliminates caps on excess APTC repayment - Restricts premium tax credits for certain lawfully present noncitizens (~300,000 projected to lose coverage) - Shortens ACA enrollment windows • Medicaid Changes: - New work requirements and eligibility conditions - Six-month eligibility redeterminations (vs. annual) - Restrictions on state provider tax financing - End of Medicaid expansion incentives for 10 non-expansion states - Eliminated Medicaid reimbursement for Planned Parenthood (temporarily blocked) • Medicare Benefits: First negotiated drug prices under IRA taking effect January 1, 2026 for 10 costliest drugs. Out-of-pocket spending cap rises to $2,100. • Projected Impact: OBBBA estimated to increase uninsured by 17 million over next decade. AMA estimates 11.8 million will lose coverage.

Sources & References

https://www.nbcnews.com/health/health-news/aca-medicaid-medicare-health-care-expensive-some-cheaper-others-rcna249526 https://www.ama-assn.org/health-care-advocacy/federal-advocacy/4-big-beautiful-bill-changes-will-reshape-care-2026 https://www.kff.org/global-health-policy/health-policy-101-international-comparison-of-health-systems/ https://www.who.int/news-room/fact-sheets/detail/universal-health-coverage-(uhc) https://www.cms.gov/ https://www.congress.gov/bill/117th-congress/house-bill/5376 https://pmc.ncbi.nlm.nih.gov/articles/PMC6775911/ https://www.tronviggroup.com/free-market-vs-monopoly-healthcare-systems/ https://www.beckerspayer.com/policy-updates/notable-health-insurance-policies-taking-effect-in-2026/ https://en.wikipedia.org/wiki/Universal_health_care_by_country https://www.commonwealthfund.org/ https://www.aarp.org/ https://www.cbo.gov/

Stay Informed

Get weekly policy updates and new issue alerts delivered to your inbox.